Design
Editorial
Answers are grounded in this paper and cite their sources.
Highlights the critical need for further research into the pathogenesis and treatment of HFpEF given its increasing prevalence and the failure of previous large clinical trials.
H eart failure (HF) with preserved ejection fraction (HFpEF) is the most common form of HF. Approximately 90% of new HF cases in older women are HFpEF. In contrast to HFrEF, the prevalence of HFpEF is increasing and its prognosis is worsening. 2 Despite the strong public health importance of HFpEF, its pathogenesis is poorly understood. Our lack of understanding of HFpEF and its treatment is punctuated by the fact that 6 large, well-designed, randomized, clinical trials and several smaller ones were all neutral on their primary outcomes. The combination of high prevalence and lack of evidence-based treatments makes HFpEF a highpriority topic for research in cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Kitzman et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: